| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | -0.34 | 2e-10 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | -0.21 | 0.0002 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | -0.27 | 0.0003 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | -0.19 | 0.001 |
| mRNA | PD-0332991 | CCLE | pan-cancer | AAC | -0.18 | 0.007 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | 0.14 | 0.01 |
| mRNA | TKI258 | CCLE | pan-cancer | AAC | -0.16 | 0.01 |
| mRNA | L-685458 | CCLE | pan-cancer | AAC | -0.11 | 0.07 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | 0.11 | 0.08 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | 0.1 | 0.1 |